Related Experiment Video
Updated: May 7, 2026

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
Published on: March 15, 2022
A strategy for addressing aspirin hypersensitivity in patients requiring urgent PCI
Patrick Schiano1, Philippe Gabriel Steg, Franck Barbou
1Hôpital d'Instruction des Armées du Val de Grâce, Paris, France.
Insights
For acute myocardial infarction patients allergic to aspirin, a strategy combining percutaneous coronary intervention with glycoprotein IIb/IIIa blockers and rapid oral desensitization offers a viable treatment path. This approach manages hypersensitivity while ensuring critical antiplatelet therapy.
Area of Science:
- Cardiology
- Pharmacology
Background:
- Aspirin is crucial for acute myocardial infarction (AMI) management, especially with stent implantation.
- Optimal treatment for aspirin-hypersensitive patients with ST-elevation AMI remains undefined.
Purpose of the Study:
- To propose and outline a management strategy for aspirin-hypersensitive patients undergoing percutaneous coronary intervention for ST-elevation AMI.
Main Methods:
- Percutaneous coronary intervention (PCI) with intravenous glycoprotein IIb/IIIa receptor blockers for antiplatelet therapy.
- Rapid oral desensitization initiated in the hours following PCI, once the patient is clinically stable.
Main Results:
- This strategy aims to provide effective antiplatelet coverage despite aspirin hypersensitivity.
- Facilitates necessary intervention in a high-risk patient population.
Conclusions:
- A combined approach of PCI, glycoprotein IIb/IIIa blockers, and rapid oral desensitization is a suggested management strategy for aspirin-hypersensitive patients with ST-elevation AMI.
- This strategy addresses the challenge of treating these patients, enabling essential interventions and therapy.
Abstract:
Aspirin is key to the treatment of acute myocardial infarction, particularly if stent implantation is considered. In patients with a history of hypersensitivity to aspirin, the optimal management of ST-segment elevation acute myocardial infarction is unclear. We suggest a strategy for addressing this problem by performing percutaneous coronary intervention with antiplatelet therapy by intravenous glycoprotein IIb/IIIa receptor blockers and performing rapid oral desensitization in the ensuing hours, once the patient has stabilized.
Related Concept Videos
Acute Coronary Syndrome IV: Interprofessional Care
Angina IV: Management
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Coronary Artery Disease V: Interprofessional Care
Acute Coronary Syndrome V: Nursing Management

